Werewolf Therapeutics

“Abros Therapeutics...agreed to a reverse merger with Werewolf Therapeutics (Nasdaq: HOWL), after having raised $154m from RA Capital Management, Enavate Sciences, and Italy's Abiogen Pharma.”